| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
1 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
1 |
| mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
0.007 |
1 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |